Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06854302Enrolling By Invitation

Angina After PCI: a Systems Medicine Study

Role: collaborator

NCT06662890Not ApplicableRecruiting

Heart Attack Blood Oxygen Therapy Trial

Role: collaborator

NCT03140111Not ApplicableUnknown

LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients

Role: collaborator

All 3 trials loaded